Open Label, Dose-Regimen Study Evaluating Etanercept 50 mg Once-Weekly In Japanese Subjects With RA
Status:
Completed
Trial end date:
2007-12-01
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to evaluate the safety and efficacy of a once-weekly
dose of etanercept for rheumatoid arthritis. Currently, patients in Japan can only use 25 mg
etanercept two times a week. If a once-a-week regimen of 50 mg is approved, this would be
more convenient for most patients. This once-weekly regimen is used in countries outside of
Japan.